You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 103 No. 3, March 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  EDITORIALS
 This Article
 •References
 •Full text PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on Web of Science (2)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Some Cons of PROs

David B. Palmer, Esq; Mr Palmer practices law in the Washington, DC, and New York City offices of Akin, Gump, Strauss, Hauer & Feld.

Arch Ophthalmol. 1985;103(3):343-345.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

It is amazing how quickly federal health care policy can come full circle. Just 31/2 years ago, the Reagan administration vehemently opposed the very existence of the federal medical review program, which was then called the Professional Standards Peer Review Organization (PSRO) program. Now, virtually the same program, under the new name of the Utilization and Quality Control Peer Review Organization, or the PRO program, is the "darling" of the federal budget cutters. The deregulation rhetoric that was in vogue at the beginning of the first term fell by the wayside when the administration perceived that PROs offered a mechanism to reduce substantially federal health care expenditures through administrative fiat. In 1984, while Congress was hotly debating whether the annual increase in prospective payments for hospitals under the diagnosis-related groups (DRGs) payment system should be limited to the inflation rate or the inflation rate plus 0.25%, the Health Care Financing . . . [Full Text PDF of this Article]


Author Affiliations

Washington, DC



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.